0001628280-20-016603.txt : 20201118 0001628280-20-016603.hdr.sgml : 20201118 20201118191933 ACCESSION NUMBER: 0001628280-20-016603 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201117 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ciesielski Helen CENTRAL INDEX KEY: 0001831757 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36533 FILM NUMBER: 201326614 MAIL ADDRESS: STREET 1: C/O MEDAVAIL TECHNOLOGIES INC. STREET 2: 6665 MILLCREEK DR, UNIT 1 CITY: MISSISSAUGA STATE: A6 ZIP: L5N 5M4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYOS RENS TECHNOLOGY INC. CENTRAL INDEX KEY: 0001402479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900772394 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HORSEHILL ROAD STREET 2: SUITE 106 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 BUSINESS PHONE: 973-509-0444 MAIL ADDRESS: STREET 1: 45 HORSEHILL ROAD STREET 2: SUITE 106 CITY: CEDAR KNOLLS STATE: NJ ZIP: 07927 FORMER COMPANY: FORMER CONFORMED NAME: MYOS Corp DATE OF NAME CHANGE: 20120521 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Therapeutics Corp DATE OF NAME CHANGE: 20100719 FORMER COMPANY: FORMER CONFORMED NAME: Rough Tide Marine Operations, Inc. DATE OF NAME CHANGE: 20100528 3 1 wf-form3_160574516038844.xml FORM 3 X0206 3 2020-11-17 1 0001402479 MYOS RENS TECHNOLOGY INC. MDVL 0001831757 Ciesielski Helen C/O MEDAVAIL HOLDINGS, INC. 6665 MILLCREEK DR. UNIT 1 MISSISSAUGA A6 L5N 5M4 ONTARIO, CANADA 1 0 0 0 Ryan Ferguson, attorney-in-fact for Helen Ciesielski 2020-11-18 EX-24 2 ex-24.htm CIESIELSKI POA

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of MedAvail Holdings, Inc. (the "Company"), hereby constitutes and appoints Ed Kilroy and Ryan Ferguson, and each of them, the undersigned's true and lawful attorney-in-fact, to:

1.    Complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his or her discretion determine to be required or advisable pursuant to Section 16 of the Exchange Act and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned's ownership, acquisition or disposition of securities of the Company; and

2.    Do all acts necessary in order to file such forms with the SEC, any securities exchange or national association, the Company and such other person or agency as the attorney-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys in-fact and agent shall do or cause to be done by virtue hereof.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 18th day of November, 2020.

Signature:    /s/ Helen Ciesielski

Print Name:    Helen Ciesielski